epirubicin has been researched along with Hypercoagulability in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirai, A; Ichiki, Y; Imanishi, N; Ishida, T; Kusanagi, K; Shinohara, S; Takeda, Y; Tanaka, F; Tashima, Y; Yoshimatsu, K | 1 |
| Beaudin, S; Liaw, PC; Shin, LY; Swystun, LL | 1 |
| Reitsma, PH; Van Den Berg, YW | 1 |
3 other study(ies) available for epirubicin and Hypercoagulability
| Article | Year |
|---|---|
[A Case Report of Luminal A Male Inflammatory Breast Cancer that Was Difficult to Treat Because of Trousseau Syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms, Male; Cilostazol; Combined Modality Therapy; Cyclophosphamide; Docetaxel; Drug Combinations; Epirubicin; Factor Xa Inhibitors; Fatal Outcome; Fluorouracil; Humans; Inflammatory Breast Neoplasms; Male; Oxonic Acid; Pyridines; Radiotherapy, Intensity-Modulated; Skin Neoplasms; Syndrome; Tegafur; Thiazoles; Thrombophilia | 2019 |
Chemotherapeutic agents doxorubicin and epirubicin induce a procoagulant phenotype on endothelial cells and blood monocytes.
Topics: Antibiotics, Antineoplastic; Blood Coagulation; Blood Coagulation Tests; Cells, Cultured; Doxorubicin; Endothelial Cells; Endothelium, Vascular; Epirubicin; Humans; Monocytes; Phenotype; Plasma; Thrombophilia | 2009 |
Not exclusively tissue factor: neutrophil extracellular traps provide another link between chemotherapy and thrombosis.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; DNA; Doxorubicin; Endothelial Cells; Epirubicin; Female; Histones; Humans; Monocytes; Neoplasms; Protein C; Thrombin; Thrombomodulin; Thrombophilia; Thromboplastin; Thrombosis | 2011 |